ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $114,781,000 | -43.7% | 1,235,000 | -63.9% | 1.95% | -39.0% |
| Q3 2021 | $203,959,000 | -26.6% | 3,425,000 | -16.0% | 3.20% | -33.7% |
| Q2 2021 | $277,915,000 | -1.1% | 4,075,000 | +0.6% | 4.84% | -0.4% |
| Q1 2021 | $281,030,000 | -12.7% | 4,050,000 | -3.3% | 4.85% | -12.5% |
| Q4 2020 | $321,918,000 | +38.8% | 4,190,000 | +35.2% | 5.54% | +68.3% |
| Q3 2020 | $231,849,000 | +287.7% | 3,100,000 | +226.3% | 3.29% | +178.7% |
| Q2 2020 | $59,803,000 | – | 950,000 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |